Healthcare AI startup Froncort.AI announced on Tuesday that it has raised $2.3 million from Google.org, the philanthropic arm of Alphabet Inc., to scale its AI‑driven disease surveillance platform.
The funding package includes $200,000 in Google Cloud credits and pro bono technical assistance from Google AI specialists. Froncort.AI will use the capital to develop mAI‑NETRA, a mobile version of its AI‑NETRA platform that combines artificial intelligence, satellite imagery and government health data to pinpoint geographic hotspots for infectious diseases and guide frontline health workers to targeted screenings.
Founded in 2024 by physician‑scientist Dr. Ujjwal Rao, the Bangalore‑based startup was selected as one of 15 global winners of Google.org’s Impact Challenge: AI for Government Innovation. In a validation study with Maharashtra’s state tuberculosis programme, Froncort.AI reported that teams using AI‑NETRA identified a comparable number of confirmed pulmonary TB cases while screening two‑thirds fewer people, cutting the cost per confirmed case from roughly $29,000 to $10,000 and reducing worker workload for 92% of participants.
Platform capabilities and future plans
AI‑NETRA integrates government programme data with Google Earth AI models and local risk indicators such as settlement density, land use, rainfall and flooding to generate ranked work paths for health workers. The startup plans to extend the platform to six infectious diseases—tuberculosis, leprosy, malaria, dengue, cholera and leptospirosis—and to release mAI‑NETRA as an open‑source blueprint for governments.
Broader context
Froncort.AI also operates RegDoc, a regulatory‑technology solution that prepares compliant submissions for clinical‑research organisations, pharmaceutical firms and medical‑device manufacturers. The capital raise arrives as India accelerates the integration of AI into its public‑health infrastructure, a move highlighted in a February government statement that cited AI tools in the National TB Elimination Programme, the National Diabetic Retinopathy Screening Programme and the Media Disease Surveillance System.